CSIMarket
M and t Bank Corporation  (MTB)
Other Ticker:  
 
    Sector  Financial    Industry Regional Banks
   Industry Regional Banks
   Sector  Financial
 
Price: $144.0200 $-2.59 -1.767%
Day's High: $150.418 Week Perf: -10.81 %
Day's Low: $ 148.00 30 Day Perf: -5.69 %
Volume (M): 64 52 Wk High: $ 168.27
Volume (M$): $ 9,590 52 Wk Avg: $146.82
Open: $149.79 52 Wk Low: $118.54



 Market Capitalization (Millions $) 18,556
 Shares Outstanding (Millions) 129
 Employees 17,503
 Revenues (TTM) (Millions $) 6,005
 Net Income (TTM) (Millions $) 1,795
 Cash Flow (TTM) (Millions $) -10
 Capital Exp. (TTM) (Millions $) 134

M And T Bank Corporation
M&T Bank Corporation is a New York business corporation which is registered as a bank holding company under the Bank Holding Company Act of 1956, as amended (“BHCA”) and under Article III-A of the New York Banking Law (“Banking Law”). The principal executive offices of the Registrant are located at One M&T Plaza, Buffalo, New York 14203.


   Company Address: One M & T Plaza Buffalo 14203 NY
   Company Phone Number: 635-4000   Stock Exchange / Ticker: NYSE MTB
   MTB is expected to report next financial results on February 21, 2022. Next quarterly dividend pay out on December 31, 2021.


Customers Net Income grew by MTB's Customers Net Profit Margin grew to

79.58 %

15 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ABCB   -100%    
ZION   -2.81%    
WTFC   -100%    
PNC   -2.32%    
KEY   -3.67%    
ASB   -100%    
• View Complete Report
   



Semileds Corp

Losses Widen, Sales Down Slightly

Weakening demand led to deficit in the fourth quarter of 2021 earnings season, Sales fell by -2% to $1.37 millions and loss per share was at $-0.40 compared to $-0.01 per share realized in quarter a year ago.

From the preceding quarter, increased losses from $-0.02 per share and Sales decreased by -4.73% from $1.44 millions.
Semileds Corp reported net loss of $-2.86 millions and Sales of $4.74 millions for the fiscal year 2021.

Net loss per share has widen to $-0.68 from $-0.15 in previous fiscal year, while Sales fell by -21.97 % from $6.07 millions a year ago.

Shoe Carnival Inc

Profits Soar by 130.99 %

Company displayed pleasant results in the most recent fiscal period. Sales were at $356.34 millions higher by 18.47% year on year and advanced by 7.26 % quarter on quarter, while earnings per share more than doubled by 130.99 % to $1.64, sequentially income improved by 6.49 %.


Cabot Corporation

Income Positive Again, Sharp Topline Growth

Cabot Corporation announced earnings per share of $0.51 and Sales of $917.00 millions in the fourth quarter of 2021, Company's earnings turn positive per share, versus $-4.82 eps, earned in the same quarter a year ago, although Cabot Corporation saw its Sales rise by 37.18% in the same period.

In the previous quarter company realized Sales of $917.00 millions and $1.48 per share.
Cabot Corporation reported earnings of $286.00 millions and Sales of $3.41 billions for the fiscal year 2021.

Company reported earnings per share of $4.34 compared to $-4.21 in the previous fiscal year, while Sales surged by 30.41 % from $2.61 billions a year ago.

Artelo Biosciences Inc

Artelo Biosciences Inc announced most recent fiscal period operating deficit of $-3.186884 millions

In the most recent fiscal period Artelo Biosciences Inc reached break-even of $-0.00 per share compared to $-0.27 a year ago and from $-0.11 per share from the previous quarter.

Artelo Biosciences Inc reported operating shortfall of $-3.186884 millions, in the most recent fiscal period, a deterioration from the operating shortfall of $-0.951395 millions, realized in fourth quarter of 2020
Artelo Biosciences Inc reported net loss of $-7.44 millions and Sales of $0.00 millions for the fiscal year 2021.

Company has decreased loss per share to $-0.40 from $-1.26 in the previous fiscal year, while by 0 % from $0.00 millions a year ago.

Lexaria Bioscience Corp

Lexaria Bioscience Corp announced financial fourth quarter of 2021 operating shortfall of $-2.916645 millions

Lexaria Bioscience Corp reported disastrous financial fourth quarter of 2021, where Sales faded by -78.66% to $0.03 millions and loss per share has widen to $-0.22, from the same quarter a year ago.

Eps dropped from the preceding quarter from $-0.50 per share, by -86.01% from $0.20 millions.
Lexaria Bioscience Corp reported net loss of $-3.87 millions and Sales of $0.72 millions for the fiscal year 2021.

Net loss per share has widen to $-0.95 from $-0.05 in previous fiscal year, while Sales surged by 84 % from $0.39 millions a year ago.






 

M And T Bank's Segments
 
Commercial Banking
 Segment    23.89 % of total Revenue
Commercial Real Estate
 Segment    16.02 % of total Revenue
Discretionary Portfolio
 Segment    1.22 % of total Revenue
Residential Mortgage Banking
 Segment    8.79 % of total Revenue
Retail Banking
 Segment    27.24 % of total Revenue
All Other
 Segment    12.89 % of total Revenue
Business Banking
 Segment    9.95 % of total Revenue
 
• View Complete Report

M And T Bank's Operating Statistics Decrease / Increase
       
• View Complete Report


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SCGY's Profile

Stock Price

SCGY's Financials

Business Description

Fundamentals

Charts & Quotes

SCGY's News

Suppliers

SCGY's Competitors

Customers & Markets

Economic Indicators

SCGY's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071